LAHORE: The University of Health Sciences (UHS) Lahore is all set to inaugurate its state-of-the-art diagnostic laboratory on ...
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal ...
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ ... to the company’s state-of-the-art laboratory facility in Salt Lake City. About Precise Molecular Residual Disease ...
The DNA in the samples is then sequenced by a lab that looks for up to more than 100 gene mutations. Either an oncologist or a primary care physician may be the one to bring up genetic testing ...
SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...
SG Americas Securities LLC cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 28.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 12,518 shares of the company ...
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent $14M Series A round that brings total funding to $32M. Who were your ...
Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...
Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease.
Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living ...
You may have heard about the large underground seed vault in Svalbard, Norway, which opened in 2008. But you might be ...